Ketan R. Patel

From Wikipedia, the free encyclopedia
Dr. Ketan Patel
Dr. Ketan Rajnibhai Patel
Born
NationalityIndian
Alma materL. M. College of Pharmacy, Dharamsinh Desai University
Occupationpharmacist, businessman

Dr. Ketan R. Patel is an Indian entrepreneur, pharmacist, chairman & managing director of Troikaa Pharmaceuticals, a research-driven pharmaceutical company, with operations in over 80 countries.[1]

Education & career[]

Dr. Patel is a Gold Medalist during his Bachelor of Pharmacy and Master of Pharmacy programs from L. M. College of Pharmacy, Ahmedabad. He has a Ph.D. in Pharmaceutical Technology from Dharamsinh Desai University, Gujarat.[2]

Dr. Patel instituted the “Rajnibhai.V. Patel Pharmlnnova Award” under the aegis of Department of Science and Technology (India).[3][4]

He is the Chairman of Board of Governors, NIPER, Ahmedabad[5] and Member of Academic Council, Gujarat Forensic Sciences University.[6] He is also a member of Board of Governors – Gujarat Technological University[7]

His journey of innovation can be found in a book names ‘THE INNOVATORS’, published by the Department of Science and Technology (India) Government of India.

Membership and Boards[]

Dr. Patel is the Chairman of the Board of Governors at National Institute of Pharmaceutical Education & Research (NIPER), Gandhinagar.[8] He is also a member of Academic Council, National Forensic Sciences University, Ahmedabad (previously known as Gujarat Forensic Sciences University).[9]

He is the member of the Board of Governors at Gujarat Technological University, Ahmedabad.[10] He is a member of the Board of Directors, i-HUB, one of the biggest startup institutes set up by the Government of Gujarat.[11]

Invention[]

Dr. Patel is the primary inventor & patent holder of a painless diclofenac injection under the brand name – ‘DYNAPAR-AQ’ by Troikaa Pharmaceuticals Ltd. For this Government of India’s Department of Science & Industrial Research also conferred National Award in 2008.[12][13]

In 2008, he invented a quick penetrating solution of Diclofenac for topical administration known as 'DYNAPAR QPS', for which he was conferred National Award in 2015 by Department of Science & Technology, Govt of India.[14]

Other Activities[]

Publications[]

  • PENETRATION OF DICLOFENAC FROM NOVEL QUICK PENETRATING SOLUTION. A COMPARATIVE SCINTIGRAPHY STUDY WITH GEL, Sanjaykumar H. Maroo, Ketan R. Patel and Aseem Bhatnagar, International Journal of Pharma & Science Res.2013;5(4):175-178
  • A Comparative Dermal Microdialysis Study of Diclofenac QPS versus Conventional 1% Diclofenac Gel, Sanjay Kumar H. Maroo1*, Ketan R. Patel, Vipul Prajapati, Rajen Shah, Milind Bagul, ISSN 0975-248X, 2013, vol5, issue4
  • Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study, Akhileshwar and Swati Singh, DOI: 10.4103/aer.AER_189_18, 2019 Jan-Mar; 13(1): 155–157, PMID 31031497
  • Evaluation of Skin Penetration of Diclofenac from a Novel Topical Non-Aqueous Solution: A Comparative Bioavailability Study, Manish Nivsarkar, Sanjaykumar Maroo, Ketan R Patel, Dixit D Patel, ISSN: 0975-8232, 2017

References[]

Retrieved from ""